PCI Biotech Holding ASA (DE:4QG) has released an update.
PCI Biotech Holding ASA, a biopharmaceutical company specializing in novel photochemical technologies, has announced a live webcast for its first half 2024 interim report scheduled for August 28, 2024. The presentation, which includes a Q&A session, will be conducted in Norwegian and accessible via the company’s website. Key developments include advancements in their photochemical lysis and internalisation technologies aimed at improving viral vector manufacturing and therapeutic delivery.
For further insights into DE:4QG stock, check out TipRanks’ Stock Analysis page.
